Treatment for Alzheimer's Disease

Overview

Treatment for Alzheimer's disease combines medicines that help symptoms, newer therapies that aim to slow the disease in selected patients, and — just as importantly — non-drug care that supports thinking, safety, mood, and quality of life. There is currently no cure and no treatment that reverses the disease.

The goals of treatment are to help the person function and feel as well as possible for as long as possible, to keep them safe, and to support their family. Plans are individual and change as the condition progresses.

This page is an educational overview for patients and families. It is not medical advice, and results vary from person to person. Treatment should be guided by a specialist who has confirmed the diagnosis and can weigh the benefits and risks of each option.

Who May Need This

Treatment is relevant for people who have been diagnosed with Alzheimer's disease after specialist assessment, at any stage from early to advanced. The specific treatments differ by stage: some symptom medicines are used earlier, others later, and newer anti-amyloid therapies are only for carefully selected early-stage patients.

Families and carers are closely involved, since much of treatment involves support, safety, and daily care. Only a qualified specialist can decide which treatments are appropriate, based on the diagnosis, stage, other health conditions, and the person's wishes.

When It May Be Recommended

Treatment is generally started once Alzheimer's disease has been diagnosed and treatable causes of memory problems have been excluded. Symptom medicines may be offered when memory and daily function are affected, while newer disease-slowing drugs are considered only in early disease with confirmed amyloid and no contraindications.

Non-drug care and carer support are recommended from the outset and throughout. The choice and timing of each treatment depend on the individual, and are decided together with the specialist and family.

Diagnosis and Evaluation

Before and during treatment, evaluation confirms the diagnosis and guides therapy. This includes cognitive testing, a full history from the person and family, blood tests to exclude other causes, and brain imaging with MRI or CT.

If newer anti-amyloid therapy is being considered, additional tests — such as a PET scan or spinal fluid test to confirm amyloid, and a baseline MRI — are required, along with a review of factors that increase the risk of side effects. Ongoing evaluation tracks response and safety, and a second opinion at a memory clinic can be valuable.

Treatment Options

Options fall into three groups. Symptom medicines — cholinesterase inhibitors and memantine — may modestly help thinking and daily function. Disease-slowing therapies — infused anti-amyloid antibodies — aim to slow decline in selected early-stage patients but carry real risks and strict eligibility. Non-drug care — routine, cognitive and physical activity, nutrition, mood and sleep management, and carer support — underpins all treatment.

Managing other conditions (blood pressure, diabetes, hearing, and vision) and reviewing medicines that can worsen thinking are also important. Your specialist will explain which combination fits the person's stage and health.

How It Is Performed

Treatment is delivered as ongoing care rather than a single procedure. A specialist prescribes and adjusts symptom medicines, monitoring for benefit and side effects, and coordinates non-drug support through therapists, nurses, and community services.

If an anti-amyloid therapy is used, it is given as regular intravenous infusions over many months, with scheduled MRI scans to watch for brain swelling or small bleeds, and is stopped if problems arise. Throughout, the care team works with the family, reviewing the plan and adapting it as the disease changes and new needs appear.

Preparation

Preparation includes a clear list of current medicines and health conditions, up-to-date cognitive assessment, and, for anti-amyloid therapy, the required confirmatory tests and baseline MRI. Understanding the realistic benefits and risks before starting any treatment is essential.

If you are seeking treatment abroad, plan for the in-country stay for assessment and any initial infusions, and arrange how ongoing dosing, monitoring, and support will continue at home. Bring copies of all records so the specialist has the full history.

Benefits and Expected Goals

The goals of treatment are to ease symptoms, help maintain daily function and independence, support safety and wellbeing, and, for eligible patients on disease-slowing therapy, to modestly slow decline. Good non-drug care and carer support can meaningfully improve quality of life.

Benefits are generally modest and vary between individuals. No treatment stops or reverses the disease, and progression continues over time. Realistic goals centre on comfort, dignity, and function rather than cure, and the specialist can explain what to expect.

Risks and Possible Complications

Every treatment has potential downsides that must be weighed against modest benefits.

• Symptom medicines can cause nausea, diarrhoea, slow heart rate, dizziness, or sleep changes
• Anti-amyloid therapies can cause brain swelling or small bleeds (seen on monitoring MRI), infusion reactions, and, rarely, serious events
• Interactions with other medicines and effects on existing health conditions
• Risks from stopping helpful treatments too early or continuing ineffective ones
• Physical, emotional, and financial strain on carers

The care team will explain the specific risks of each option and monitor closely, particularly during anti-amyloid therapy. Report any concerning symptoms promptly.

Recovery, Follow-up & Aftercare

Because Alzheimer's is progressive, treatment is about ongoing management rather than recovery. Regular follow-up reviews how medicines are working and tolerated, tracks the person's function and safety, and adjusts the plan as needs change.

Aftercare includes practical support — occupational therapy, home adaptations, day services, and later more intensive care — and dedicated support for carers. If treatment began abroad, arrange continuing prescriptions, monitoring (including any required MRIs), and support with a doctor close to home before travelling back.

Medical Tourism Planning

If you are seeking Alzheimer's treatment abroad, choose a JCI- or ISO-accredited hospital with a neurology or memory-clinic programme and modern imaging. Verify the specialist's experience with dementia and, where relevant, with the safe use and MRI monitoring of newer therapies. Request a written treatment plan and cost estimate before you travel.

Because this treatment is long-term, the most important planning is how ongoing care will continue at home. Any medication started abroad must be safely continued and supervised locally. Consider comprehensive travel and medical insurance.

Estimated Cost Factors

Cost depends on the country and hospital, the specialist fees, the tests required (cognitive assessment, blood tests, MRI, and for newer therapies PET or spinal fluid tests), the medicines used, and ongoing care. Newer infused anti-amyloid therapies and their monitoring are substantially more expensive than symptom medicines.

Many international destinations offer assessment and care at a fraction of typical US prices, but figures vary widely. Prices quoted online are only estimates — always request a personalized written quote for the specific treatment and monitoring needed before making any decision.

Choosing a Hospital or Specialist

Look for a hospital with recognised accreditation (JCI, ISO, or a strong national equivalent), a neurology or geriatric-medicine service with a memory clinic, and modern imaging. Confirm the specialist's experience with dementia treatment and, if considering anti-amyloid therapy, their protocols for eligibility and MRI safety monitoring.

Ask about international patient services, interpreter support, and how ongoing treatment and family support would be coordinated with your home doctors. A multidisciplinary team and transparent written treatment and cost plans are good signs of a quality service.

Alternatives

Alternatives and complements to medication include non-drug care (cognitive stimulation, exercise, structured routine, and social engagement), treating other health conditions that affect thinking, and, for eligible early-stage patients, participation in clinical trials of investigational treatments. For many people, non-drug care is the mainstay.

Be wary of unproven "cures" and costly supplements — none reverses Alzheimer's disease, and some may be harmful. Discuss all evidence-based options with your specialist so the plan fits the person's stage, health, and wishes.

Questions to Ask Your Doctor

• Which treatments are appropriate for this stage, and what are their realistic benefits?
• What side effects should we watch for, and how will they be monitored?
• Is the person eligible for anti-amyloid therapy or a clinical trial, and what does it involve?
• How will we know if a treatment is helping or should be stopped?
• What non-drug care and carer support do you recommend?
• If treatment starts abroad, how will dosing and monitoring continue at home?
• What is included in the cost estimate, including tests and monitoring?